Actovegin is a biological drug derived from calf blood, containing a complex mixture of biologically active substances such as amino acids, microelements, nucleosides, and small molecular weight compounds. These components are believed to have beneficial effects on cellular metabolism and oxygen utilization, promoting tissue repair and recovery.
Usage:
Used in Pharmaceutical Industry:
Actovegin is used as a treatment for peripheral vascular disease, enhancing blood flow and improving oxygen and nutrient delivery to affected tissues.
Actovegin is used as a therapy for diabetic polyneuropathy, supporting nerve cell metabolism and aiding in the healing process.
Actovegin is used for wound healing, promoting the transport and utilization of oxygen and nutrients by cells, as well as stimulating the release of growth factors and other proteins involved in tissue regeneration and healing.
Usage:
Used in Pharmaceutical Industry:
Actovegin is used as a treatment for peripheral vascular disease, enhancing blood flow and improving oxygen and nutrient delivery to affected tissues.
Actovegin is used as a therapy for diabetic polyneuropathy, supporting nerve cell metabolism and aiding in the healing process.
Actovegin is used for wound healing, promoting the transport and utilization of oxygen and nutrients by cells, as well as stimulating the release of growth factors and other proteins involved in tissue regeneration and healing.
63748-11-8
Post Buying Request-
-
Basic information
- Product Name: Actovegin
- Synonyms: Actovegin;deproteinized heModerivative of calf blood;MF 125
- CAS NO:63748-11-8
- Molecular Formula:
- Molecular Weight: 0
- EINECS: N/A
- Product Categories: N/A
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: N/A
- Refractive Index: N/A
- Storage Temp.: N/A
- Solubility: N/A
- CAS DataBase Reference: Actovegin(CAS DataBase Reference)
- NIST Chemistry Reference: Actovegin(63748-11-8)
- EPA Substance Registry System: Actovegin(63748-11-8)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 63748-11-8(Hazardous Substances Data)
63748-11-8 Suppliers
Recommended suppliers
63748-11-8 Usage
Check Digit Verification of cas no
The CAS Registry Mumber 63748-11-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,7,4 and 8 respectively; the second part has 2 digits, 1 and 1 respectively.Calculate Digit Verification of CAS Registry Number 63748-11:
(7*6)+(6*3)+(5*7)+(4*4)+(3*8)+(2*1)+(1*1)=138
138 % 10 = 8
So 63748-11-8 is a valid CAS Registry Number.
63748-11-8Upstream product
63748-11-8Downstream Products
63748-11-8Related news
A prospective, randomized, multi-center trial to investigate Actovegin (cas 63748-11-8) in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma07/14/2019
PurposeA multi-center prospective randomized trial was conducted to evaluate the efficacy and safety of Actovegin in the prevention and treatment of chemoradiotherapy-induced acute oral mucositis.detailed
Predictors of response to treatment with Actovegin (cas 63748-11-8) for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy07/12/2019
AimsTo evaluate two definitions of response and the predictive value of baseline covariates for response to actovegin treatment in type 2 diabetic patients with symptomatic diabetic sensorimotor polyneuropathy (DSPN).detailed
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 63748-11-8
Actovegin
